Citadel Advisors’s Dentsply Sirona XRAY Stock Holding History

Citadel Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.43M	Buy	209,600 +36,200	+21%	+$451K	﹤0.01%	5680
2025 Q4	$1.98M	Buy	173,400 +48,100	+38%	+$565K	﹤0.01%	5933
2025 Q3	$1.59M	Buy	125,300 +57,300	+84%	+$831K	﹤0.01%	6535
2025 Q2	$1.08M	Sell	68,000 -310,100	-82%	-$4.64M	﹤0.01%	6925
2025 Q1	$5.65M	Sell	378,100 -49,400	-12%	-$875K	﹤0.01%	3685
2024 Q4	$8.11M	Buy	427,500 +86,400	+25%	+$1.83M	﹤0.01%	3249
2024 Q3	$9.23M	Buy	341,100 +324,700	+1,980%	+$8.29M	﹤0.01%	3032
2024 Q2	$409K	Sell	16,400 -20,000	-55%	-$574K	﹤0.01%	8468
2024 Q1	$1.21M	Buy	36,400 +12,400	+52%	+$424K	﹤0.01%	6550
2023 Q4	$854K	Buy	24,000 +6,900	+40%	+$219K	﹤0.01%	6986
2023 Q3	$584K	Buy	17,100 +1,500	+10%	+$57K	﹤0.01%	7718
2023 Q2	$624K	Sell	15,600 -24,400	-61%	-$970K	﹤0.01%	7446
2023 Q1	$1.57M	Buy	40,000 +5,100	+15%	+$187K	﹤0.01%	5829
2022 Q4	$1.11M	Buy	34,900 +15,900	+84%	+$479K	﹤0.01%	6607
2022 Q3	$539K	Sell	19,000 -24,900	-57%	-$851K	﹤0.01%	8305
2022 Q2	$1.57M	Buy	43,900 +4,900	+13%	+$198K	﹤0.01%	6049
2022 Q1	$1.92M	Sell	39,000 -253,200	-87%	-$13.4M	﹤0.01%	6172
2021 Q4	$16.3M	Buy	292,200 +242,000	+482%	+$13.3M	﹤0.01%	2291
2021 Q3	$2.91M	Buy	50,200 +2,300	+5%	+$142K	﹤0.01%	5435
2021 Q2	$3.03M	Buy	47,900 +10,800	+29%	+$711K	﹤0.01%	5577
2021 Q1	$2.37M	Sell	37,100 -3,600	-9%	-$209K	﹤0.01%	6006
2020 Q4	$2.13M	Sell	40,700 -29,700	-42%	-$1.46M	﹤0.01%	5232
2020 Q3	$3.08M	Sell	70,400 -181,900	-72%	-$8.04M	﹤0.01%	3942
2020 Q2	$11.1M	Buy	252,300 +207,300	+461%	+$8.77M	﹤0.01%	2099
2020 Q1	$1.75M	Buy	45,000 +38,400	+582%	+$1.96M	﹤0.01%	4370
2019 Q4	$373K	Sell	6,600 -16,000	-71%	-$892K	﹤0.01%	7254
2019 Q3	$1.21M	Sell	22,600 -7,600	-25%	-$408K	﹤0.01%	5268
2019 Q2	$1.76M	Buy	30,200 +2,200	+8%	+$118K	﹤0.01%	4734
2019 Q1	$1.39M	Sell	28,000 -4,700	-14%	-$207K	﹤0.01%	5032
2018 Q4	$1.22M	Sell	32,700 -69,900	-68%	-$2.54M	﹤0.01%	5007
2018 Q3	$3.87M	Buy	102,600 +68,700	+203%	+$2.86M	﹤0.01%	3349
2018 Q2	$1.48M	Buy	33,900 +5,500	+19%	+$258K	﹤0.01%	4560
2018 Q1	$1.43M	Buy	28,400 +20,400	+255%	+$1.2M	﹤0.01%	4255
2017 Q4	$527K	Sell	8,000 -5,200	-39%	-$331K	﹤0.01%	5570
2017 Q3	$789K	Buy	+13,200	New	+$785K	﹤0.01%	4646
2017 Q1	–	Sell	-6,000	Closed	-$346K	–	8129
2016 Q4	$346K	Buy	+6,000	New	+$354K	﹤0.01%	5478
2016 Q1	–	Sell	-700	Closed	-$43K	–	8114
2015 Q4	$43K	Sell	700 -300	-30%	-$17.8K	﹤0.01%	7429
2015 Q3	$51K	Sell	1,000 -5,500	-85%	-$293K	﹤0.01%	7569
2015 Q2	$335K	Buy	6,500 +2,300	+55%	+$119K	﹤0.01%	5593
2015 Q1	$214K	Sell	4,200 -4,000	-49%	-$206K	﹤0.01%	6096
2014 Q4	$437K	Buy	8,200 +200	+3%	+$10.2K	﹤0.01%	4914
2014 Q3	$365K	Sell	8,000 -500	-6%	-$23.5K	﹤0.01%	5029
2014 Q2	$402K	Sell	8,500 -5,200	-38%	-$242K	﹤0.01%	4681
2014 Q1	$631K	Sell	13,700 -900	-6%	-$41.7K	﹤0.01%	4023
2013 Q4	$708K	Buy	14,600 +10,200	+232%	+$477K	﹤0.01%	3601
2013 Q3	$191K	Buy	4,400 +100	+2%	+$4.27K	﹤0.01%	4811
2013 Q2	$176K	Buy	+4,300	New	+$179K	﹤0.01%	4776

Other funds holding XRAY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Citadel Advisors's XRAY Position: Q1 2026 in Review

Citadel Advisors reduced its Dentsply Sirona (XRAY) stake by 19% in Q1 2026, selling an estimated $4.19M and leaving 1,393,463 shares worth $16.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

Citadel Advisors first reported a position in XRAY in Q2 2013 and has held it in 51 quarters since. The position peaked at $127M in Q4 2023. 384 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

Citadel Advisors held 1,393,463 shares of Dentsply Sirona worth $16.2M as of Q1 2026.
Citadel Advisors sold 336,184 Dentsply Sirona shares in Q1 2026, an estimated $4.19M.
Dentsply Sirona made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2599 holding.
Citadel Advisors first reported a position in Dentsply Sirona in Q2 2013 and has held it in 51 quarters since.
Citadel Advisors's Dentsply Sirona position peaked at $127M in Q4 2023.
384 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.